OPTN - multi bottom - upcoming catalystThis is not a financial advice!
Needs to break 2 level for further up move.
Most info on the chart.
Trade carefully!
−0.32USD
−35.48 MUSD
70.99 MUSD
80.41 M
About OptiNose, Inc.
Sector
CEO
Ramy A. Mahmoud
Headquarters
Yardley
Website
Employees (FY)
132
Founded
2000
ISIN
US68404V1008
FIGI
BBG00HS39G73
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
OptiNose: Maximum OptimismGood afternoon.
I would be glad if you subscribe to me in TradingView so you can be the first to read my new ideas. Overly grateful for your likes. In the comments, you can ask questions about the company.
Summary:
Technical analysis:
On the chart, we can see the completion of cor
OPTINOSE: "Rocket launch"Greetings
Summary:
Fundamental Analysis:
Full year 2020 XHANCE prescriptions increased 70% compared to full year 2019
Company expects top-line results from one of its clinical trials evaluating XHANCE as a potential treatment for Chronic Sinusitis by the end of 2021
In Apri
OPTN Technical Analysis 🧙OptiNose Inc is a US-based specialty pharmaceutical company which focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, which utilizes proprietary breath powered exhala
OPTN is one of the best stocks I have ever seen in a while.OPTN is one of the best stocks I have ever seen in a while.
OPTN Technical Analysis 🧙OptiNose Inc is a US-based specialty pharmaceutical company which focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, which utilizes proprietary breath powered exhala
OPTN Follow Your Nose!OPTN risk to reward ratio looks phenomenal right now. We have horizontal price support, uptrend price support, horizontal RSI support, hidden bullish RSI divergence, and a recent gap fill. Based on the prior signals, I'm targeting +30% gain in less than 2 weeks to fill the gap at $6.40. This setu
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of OPTN is 0.93 USD — it has decreased by 9.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange OptiNose, Inc. stocks are traded under the ticker OPTN.
OptiNose, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
OPTN stock is 14.68% volatile and has beta coefficient of −0.07. Check out the list of the most volatile stocks — is OptiNose, Inc. there?
One year price forecast for OptiNose, Inc. has a max estimate of 5.00 USD and a min estimate of 3.00 USD.
OPTN earnings for the last quarter are −0.08 USD whereas the estimation was −0.09 USD which accounts for 15.21% surprise. Estimated earnings for the next quarter are −0.09 USD. See more details about OptiNose, Inc. earnings.
OptiNose, Inc. revenue for the last quarter amounts to 19.82 M USD despite the estimated figure of 18.68 M USD. In the next quarter revenue is expected to reach 19.26 M USD.
Yes, you can track OptiNose, Inc. financials in yearly and quarterly reports right on TradingView.
OPTN stock has fallen by 26.37% compared to the previous week, the month change is a 51.43% fall, over the last year OptiNose, Inc. has showed a 53.38% decrease.
OPTN net income for the last quarter is −9.97 M USD, while the quarter before that showed −9.29 M USD of net income which accounts for −7.24% change. Track more OptiNose, Inc. financial stats to get the full picture.
Today OptiNose, Inc. has the market capitalization of 114.91 M, it has decreased by 5.67% over the last week.
No, OPTN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OPTN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OptiNose, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 132.00 employees. See our rating of the largest employees — is OptiNose, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OptiNose, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OptiNose, Inc. stock shows the sell signal. See more of OptiNose, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OptiNose, Inc. future price: according to them, OPTN price has a max estimate of 5.00 USD and a min estimate of 3.00 USD. Read a more detailed OptiNose, Inc. forecast: see what analysts think of OptiNose, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OptiNose, Inc. EBITDA is −22.35 M USD, and current EBITDA margin is −31.48%. See more stats in OptiNose, Inc. financial statements.